
Real-world Effectiveness of Dupilumab Vs Benralizumab and Vs Mepolizumab in Severe Asthma: The EU-ADVANTAGE study
This study was presented by Dr Johann Christian Virchow (Germany) et al., at the European Respiratory Society Congress (ERS) Congress

This study was presented by Dr Johann Christian Virchow (Germany) et al., at the European Respiratory Society Congress (ERS) Congress

This Cohort study results was presented by Mr. Michael Pollack et al from the BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA

This study was presented by Dr Priti Meshram (Mumbai, India) et al., at the European Respiratory Society Congress (ERS) Congress

This study was presented by Dr Mohamed Hamouda (United Arab Emirates) et al., at the European Respiratory Society Congress (ERS)

This retrospective analysis was presented by Prof. Nikita Ermolaev et al. from Medical University of Vienna, Vienna, Austria at the

This study was presented by Prof Pernilla Sönnerfors et al. from Respiratory Medicine Unit, Department of Medicine Solna, Karolinska Institutet,

This session was presented by Adzoa Ekue et al. from Mereo BioPharma Group plc, London, United Kingdom. at the ERS

These phase 2 trial results was presented by Dr Professor Frits Franssen et al. from Maastricht University Medical Centre Netherlands

This study was presented by Dr Luis Javier Nannini et al. from Pulmonary Section, Hospital E Perón, Universidad Nacional Rosario,

This case report was presented by Prof. Antonio Maiorano et al from Department of Health Sciences, University “Magna Graecia” of